Cancer Prevention Not Yet Recovered From Pandemic-Era Declines, Report Says
Medically reviewed by Drugs.com.
By Dennis Thompson HealthDay Reporter
THURSDAY, April 24, 2025 -- The effects of COVID-19 continue to reverberate in the cancer risk factors of Americans, a new American Cancer Society (ACS) study says.
Screening for breast and colon cancers has rebounded after decreasing or stalling during pandemic-era lockdowns, researchers reported April 23 in the journal Cancer Epidemiology, Biomarkers & Prevention.
And, despite the pandemic, smoking rates have continued to go down, researchers said.
However, cervical cancer screening remains lower than pre-pandemic levels, and the HPV vaccination rate has not increased since the pandemic, researchers found.
Other major cancer risk factors like excess weight, physical inactivity and heavy alcohol use did not budge during the pandemic, marking a lack of progress, the study said.
“Cancer prevention and early detection are central to the American Cancer Society’s goal to ensure everyone has an opportunity to prevent, detect, treat, and survive cancer,” lead researcher Dr. Priti Bandi, scientific director of cancer risk factors and screening surveillance research at the ACS, said in a news release.
“These latest findings are encouraging, mainly the reduction in smoking rates and screening for certain cancers, but it’s clear urgent efforts are needed to address lagging cervical cancer prevention,” Bandi added.
An estimated 40% of U.S. cancer cases are attributable to risk factors that people can change, researchers said.
These factors include smoking, excess weight, diet, exercise, exposure to ultraviolet radiation and infection with seven cancer-causing germs like HPV.
Cancer screening tests prevent thousands of cases and deaths every year, by detecting cancers in people with risk factors, researchers said.
For this new study, researchers analyzed data from four federal health surveys that track different cancer risk factors.
Results showed that:
“Our report underscores the need to strengthen efforts to improve access and receipt of preventive services, including cancer screening, HPV vaccination, and counseling and treatment for tobacco dependence,” senior researcher Dr. Ahmedin Jemal, senior vice president of surveillance and health equity science at the ACS, said in a news release.
However, ACS experts said these advances against cancer could be reversed if the Trump administration undermines staffing and funding of federal health agencies.
“These findings only further prove how investments in tobacco control have helped reduce the number of people falling prey to Big Tobacco’s deadly products and practices,” Lisa Lacasse, president of the ACS Cancer Action Network, said in a news release.
“Federal agencies have played a major role in helping to drive the successful reduction of smoking rates through critical tobacco control programs and funding,” she continued. “We are deeply concerned that recent cuts to these important agencies will jeopardize continued progress to reduce tobacco utilization nationwide.”
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-04-25 00:00
Read more

- ACP: Guidance Provided for Use of Cannabis in Chronic Noncancer Pain Management
- Antibiotic Noninferior to Ceftriaxone + Azithromycin for Gonorrhea
- AZD0780, a Novel Oral PCSK9 Inhibitor, Demonstrated Significant LDL Cholesterol (LDL-C) Reduction in PURSUIT Phase IIb Trial
- New Endangered Species Rule Would No Longer Count Habitat Loss as 'Harm'
- Gum May Be a Hidden Source of Microplastics
- GLP-1 Drug Use For Weight Loss Has Soared, Costing Billions
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions